Stocks
MeiraGTx Holdings plcMGTX
NASDAQHealthcareBiotechnology$10.69
Price as of · delayed, not real-time
A clinical-stage gene therapy company developing treatments for rare genetic diseases, including inherited retinal disorders and xerostomia. Its lead candidates are in late-stage trials, and investors track it for its proprietary gene regulation platform and manufacturing capabilities.
52W Range: $6.62-$15.35
Congressional Interest in MeiraGTx Holdings plc (MGTX)
1 member of Congress has disclosed 1 trade in MeiraGTx Holdings plc (MGTX), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading MGTX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2016-10-05 | MICHAEL T. MCCAUL | sell | $1K-$15K |